EI
IDYA icon

EAM Investors’s IDEAYA Biosciences IDYA Stock Holding History

EAM Investors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-83,484
Closed -$3.66M – 293
2024
Q1 		$3.66M Sell
83,484
-24,626
-23% -$1.06M 0.57% 90
2023
Q4 		$3.85M Buy
108,110
+20,448
+23% +$610K 0.68% 42
2023
Q3 		$2.37M Buy
87,662
+52,299
+148% +$1.33M 0.46% 72
2023
Q2 		$831K Buy
+35,363
New +$727K 0.15% 246
2021
Q3 		– Sell
-48,810
Closed -$1.02M – 331
2021
Q2 		$1.02M Sell
48,810
-16,761
-26% -$344K 0.16% 293
2021
Q1 		$1.54M Buy
+65,571
New +$1.27M 0.23% 211
2020
Q4 		– Sell
-117,842
Closed -$1.48M – 339
2020
Q3 		$1.48M Sell
117,842
-5,146
-4% -$63.7K 0.35% 109
2020
Q2 		$1.75M Buy
+122,988
New +$969K 0.39% 119

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

EAM Investors's IDYA Position: Q2 2024 in Review

EAM Investors sold out of IDEAYA Biosciences (IDYA) in Q2 2024, closing a stake of 83,484 shares — an estimated $3.66M sold.

EAM Investors first reported a position in IDYA in Q2 2020 and held it in 8 quarters. The position peaked at $3.85M in Q4 2023. 199 funds tracked by Wall St. Rank hold IDYA as of Q2 2024.

  • EAM Investors reported no remaining IDEAYA Biosciences position as of Q2 2024 after selling out during the quarter.
  • EAM Investors sold 83,484 IDEAYA Biosciences shares in Q2 2024, an estimated $3.66M.
  • EAM Investors first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 8 quarters.
  • EAM Investors's IDEAYA Biosciences position peaked at $3.85M in Q4 2023.
  • 199 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2024.

Based on EAM Investors's 13F filing for Q2 2024, filed 12 Aug 2024.